Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$333,399,877
-$89,736,517 QoQ
Shares Held
1,312,753
-24.2% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#138
of 4,676 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. JNJ ranks #2 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,399,877 | 1,312,753 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $423,136,394 | 1,731,044 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $385,603,310 | 1,863,268 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $206,409,913 | 1,113,202 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $390,885,568 | 2,558,989 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $308,765,554 | 1,861,828 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $395,192,080 | 2,732,624 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $378,631,796 | 2,336,368 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $477,517,581 | 3,267,088 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $387,566,605 | 2,450,007 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $208,000,874 | 1,327,044 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $286,051,071 | 1,836,604 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $390,000,705 | 2,356,215 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $146,406,645 | 944,559 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $232,689,384 | 1,317,234 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $170,142,542 | 1,041,519 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $154,168,499 | 868,506 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $210,385,655 | 1,187,077 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $286,374,771 | 1,674,021 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||